WCN24-628 SULFORAPHANE SUPPLEMENTATION INCREASES HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN HEMODIALYSIS PATIENTS
Saved in:
| Main Authors: | Ludmila Cardozo, Marcia Ribeiro, Michelli Souza, Julie Julie Ann Kemp, Marcelo Marcelo Ribeiro-Alves, Denise Mafra |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924005400 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
WCN24-701 EFFECTS OF SULFORAPHANE SUPPLEMENTATION ON PLASMA LEVELS OF UREMIC TOXINS IN PATIENTS UNDERGOING HEMODIALYSIS
by: Denise Mafra, et al.
Published: (2024-04-01) -
WCN24-746 SUPPLEMENTATION WITH SULFORAPHANE INCREASES NRF2 mRNA EXPRESSION IN NONDIALYSIS CKD PATIENTS
by: Denise Mafra, et al.
Published: (2024-04-01) -
WCN24-893 RESISTANT STARCH DOES NOT INFLUENCE LIPOPROTEIN SUBFRACTIONS PROFILE IN HEMODIALYSIS PATIENTS
by: Denise Mafra, et al.
Published: (2024-04-01) -
WCN24-1231 Propolis supplementation decreases oxLDL plasma levels in patients undergoing hemodialysis
by: Larissa Fonseca, et al.
Published: (2024-04-01) -
Trimethylamine N-Oxide (TMAO) Plasma Levels in Patients with Different Stages of Chronic Kidney Disease
by: Marcia Ribeiro, et al.
Published: (2024-12-01)